Par Pharmaceutical competitors

Par Pharmaceutical Competitors include Cipla, STERIS, BioScrip and Cytokinetics.
Add company...
Par Pharmaceutical
Par Pharmaceutical
Par Pharmaceutical, headquartered in Chestnut Ridge, NY, develops, manufactures and markets safe, innovative and cost-effective generic pharmaceutical products that help improve patient quality of life.
Cipla
Cipla
Cipla is a global pharmaceutical company, which develops and produces drugs for the treatment of arthritis, diabetes, weight control, depression and cardiovascular diseases.
STERIS
STERIS
STERIS Corporation offers customized infection prevention and contamination control solutions for a variety of environments.
BioScrip
BioScrip
We are a national post-acute solutions provider with over 30 years of experience.
Cytokinetics
Cytokinetics
We are focused on discovering and developing muscle activators as drug candidates for debilitating diseases.
Founding Date
Founding Date
1978
Founding Date
1935
Founding Date
1987
Founding Date
N/A
Founding Date
1997
Type
Type
Subsidiary
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Chestnut Ridge, US HQ
Locations
Mumbai, IN HQ
South Melbourne, AU
Hyderabad, IN
Windhoek, NA
Bloemfontein, ZA
Westville, ZA
Cape Town, ZA
see more
Locations
Mentor, US HQ
Mentor, US
Locations
Denver, US HQ
Elmsford, US
Eden Prairie, US
Locations
South San Francisco, US HQ
Employees
Employees
N/A
Employees
23,043
Employees
12,000
Employees
1,727
Employees
137
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
10.3 b
Valuation ($)
462.2 m
Valuation ($)
432.2 m
Twitter followers
Twitter followers
N/A
Twitter followers
4.3 k
Twitter followers
2.7 k
Twitter followers
291
Twitter followers
680

Financial

Revenue (est.)
Revenue (est.)
$246.1m (FY, 2014)
Revenue (est.)
N/A
Revenue (est.)
$2.6b (FY, 2018)
Revenue (est.)
$817.2m (FY, 2017)
Revenue (est.)
$13.4m (FY, 2017)
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$1.5b (FY, 2018)
Cost of goods
$547.9m (FY, 2017)
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
$1.1b (FY, 2018)
Gross profit
$269.2m (FY, 2017)
Gross profit
N/A
Net income
Net income
($32.5m) (FY, 2014)
Net income
N/A
Net income
$290.9m (FY, 2018)
Net income
($64.2m) (FY, 2017)
Net income
($127.8m) (FY, 2017)
For sources of this data, please see the company profileDownload Excel

View company profiles

Cipla
HQ
Mumbai, IN
Employees
23,043

Cipla is a global pharmaceutical company, which develops and produces drugs for the treatment of arthritis, diabetes, weight control, depression and cardiovascular diseases.

View company
STERIS
HQ
Mentor, US
Employees
12,000

STERIS Corporation offers customized infection prevention and contamination control solutions for a variety of environments.

View company
BioScrip
HQ
Denver, US
Employees
1,727

We are a national post-acute solutions provider with over 30 years of experience.

View company
Cytokinetics
HQ
South San Francisco, US
Employees
137

We are focused on discovering and developing muscle activators as drug candidates for debilitating diseases.

View company